Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-24 @ 5:41 PM
NCT ID:
NCT06539468
Eligibility Criteria:
Inclusion Criteria:
* Subject of any gender aged ≥ 65 years at the time of enrollment
* Patient at University of Michigan Department of Dermatology (UMichDD)
* Willing and able to provide informed consent
* Willing and able to comply with the protocol requirements
* Histopathologic diagnosis of one or more LR-BCC(s) within 2 months of enrollment. LR-BCC is defined here as biopsy proven primary (not recurrent) BCC of any morphologic subtype; \< 2cm in size; with or without marginal involvement on histopathology; and located on the trunk or extremities excluding pretibial surface, hands, feet, nail units, and ankles (corresponding to area L in the Mohs Appropriate Use Criteria, representing the lowest risk areas)
Exclusion Criteria:
* Individuals who are immunocompromised per judgement of investigator (examples include but are not limited to patients on immunosuppressive medications such as prednisone \> 10 mg daily, uncontrolled HIV, and organ transplant recipients on immunosuppressive therapy)
* Individuals who expect to relocate and will be unable to return to UMichDD for clinical follow-up visit(s)
* Individuals with a genetic syndrome predisposing to development of basal cell carcinoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT06539468
Study Brief:
Protocol Section:
NCT06539468